Restricted accessResearch articleFirst published online 2007-4
A Pilot Randomized Controlled Crossover Study Comparing Regional Heparinization to Regional Citrate Anticoagulation for Continuous Venovenous Hemofiltration
To evaluate the efficacy and safety of a regional heparinization and a regional citrate method of anticoagulation in CVVH.
Design
Randomized controlled cross-over study
Subjects
Ten critically ill patients with acute renal failure
Setting
ICU of tertiary hospital
Intervention
CVVH was performed with pre-filter fluid replacement at 2000ml/h and a blood flow rate of 150ml/min. Regional heparinization was by the administration of heparin pre-filter at 1500IU/h and protamine post-filter at 15mg/h. Regional citrate anticoagulation was by means of a citrate-based replacement fluid (14 mmol/L) administered pre-dilution.
Results
We studied nine males and one female. The mean age and APACHE II score were 70.5 and 17 respectively. Median circuit life was 13 hours (IQR 9.28) for the regional heparinization method compared to 17 hours (IQR 12,19.5) for the regional citrate method (p=0.77). There were no episodes of bleeding in either group.
Conclusion
Regional heparinization and regional citrate anticoagulation achieve similar circuit life in critically ill patients receiving CVVH.
UchinoS., FealyN., BaldwinI., MorimatsuH., BellomoR.Continuous is not continuous: The incidence and impact of circuit down time on uremic control during continuous veno-venous haemofiltration.Intensive Care Med2003; 29: 575–8.
2.
FealyN., BaldwinI., BellomoR.The effect of circuit “down time” on uraemic control during continuous veno-venous haemofiltration.Crit Care Resusc2002; 4: 266–70.
3.
BaldwinI., BridgeN., ElderkinT.Nursing Issues, practices, and perspectives for the management of continuous renal replacement therapy in the intensive care unit.Crit Care Nephrol1998; 1309–25.
Van de WeteringJ., WestendropR.G., HoevenJ.G., Van der StolkB., FeuthJ.D., ChangP.C.Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage.J Am Soc Nephrol1996; 7: 145–50.
7.
ReevesJ., CummingA., GallagherL., O'BrienJ., SanatamariaJ.A controlled trial of low molecular weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.Crit Care Med1999; 27: 2224–8.
8.
FiaccadoriE., MaggioreU., RotelliC.Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.Intensive Care Med2002; 28: 586–93.
9.
OhtakeT., HirasawaH., SugaiT.Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration.Contrib Nephrol1991; 93: 215–7.
PrasadG.V.Factors affecting system clotting in continuous renal replacement therapy: Results of a randomised, controlled trial.Clin Nephrol2000; 53: 55–60.
12.
UchinoS., FealyN., BaldwinI., MorimatsuH., BellomoR.Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control.Nephron2003; 94: 94–8.
13.
Van der VoortP., GerritsenR., KuiperM., EgbersP., KingmaW., BoermaE.Filter run time in CVVH: Pre versus post dilution and nadroparin versus regional heparin-protamine anticoagulation.Blood Purif2005; 23: 175–80.
14.
TanH., BaldwinI., BellomoR.Continuous venovenous hemofiltration without anticoagulation in high-risk patients.Intensive Care Med2000; 26: 1652–7.
15.
DavenportA.The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.Am J Kidney Dis1997; 30: s20–7.
16.
MorabitoS., GuzzoI., SolazzoA., MuziL., LucianiR., PierucciA.Continuous renal replacement therapies: Anticoagulation in the critically ill at high risk of bleeding.J Nephrol2003; 16: 566–71.
17.
StefanidisI., HagelJ., MaurinN.Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration.Contrib Nephrol1995; 116: 145–9.
18.
BiancofioreG., EspositoM., BindiL.. Regional filter heparinization for continuous venovenous hemofiltration in liver transplant recipients.Minerva Anesthesiology2003; 69: 527–34.
CarrJ., SilvermanN.The heparin-protamine interaction. A review.J Cardiovasc Surg1999; 40: 659–66.
21.
MehtaR., McDonaldB., AguilarM., WardD.Regional citrate anticoagulation in continuous arteriovenous hemodilaysis in critically ill patients.Kidney Int1990; 38: 976–81.
22.
ThoenenM., SchmidE., BinswangerU., SchuepbachR., AerneD., SchmidlinD.Regional citrate anticoagulation using citrate based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.Klin Wochenchrift2002; 114: 108–14.
23.
HoffmanM., MaloneyC., WardD., BeckerB.A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF).Ren Fail2002; 24: 325–35.
24.
GabuttiL., MaroneC., GiuseppeC., FrancescaD., SchonholzerC.Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge.Intensive Care Med2002; 28: 1419–25.
25.
TobeS., AujlaP., WaleleA.. A novel regional citrate anticoagulation protocol for CRRT using commercially available solutions.J Crit Care2003; 18: 121–9.
26.
MitchellA., DaulA., BeiderlindenM.. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).Clin Nephrol2003; 59: 106–14.
27.
MonchiM., BerghmansD., LedouxD., CanivetJ., DuboisB., DamasP.Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomised study.Intensive Care Med2005; 30: 260–5.
28.
KutsogiannisD., GibneyR., StolleryD., GaoJ.Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.Kidney Int2005; 67: 2361–7.
29.
BellomoR., RoncoC., KellumJ.A., MehtaR.L., PalevskyP., and the ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the ADQI Group.Critical Care2004; 8: R204–12.
30.
BellomoR., TeedeH., BoyceN.Anticoagulation regimens in acute continuous hemodiafiltration.Intensive Care Med1993; 19: 329–32.
31.
EgiM., NakaT., BellomoR.. A comparison of two citrate anticoagulation regimens for continuous venvenous hemofiltration.Artificial Kidney and Dialysis2005; 28: 1211–8.
